Logo 1.png
Aeterna Zentaris Abstract Accepted for Presentation at 13th International Congress on Autoimmunity
April 11, 2022 08:05 ET | Aeterna Zentaris Inc
– Company to present regarding AIM Biologicals as a potential therapeutic treatment option for neuromyelitis optica spectrum disorder ("NMOSD"), an orphan indication with strong unmet medical need ...